Cargando…

From biomarkers to therapeutic targets: the promise of PD-L1 in thyroid autoimmunity and cancer

The programmed cell death-1/programmed cell death ligand-1 (PD-1/PD-L1) immune checkpoint proteins hold promise as diagnostic, prognostic, and therapeutic targets for precision oncology. By restoring antitumor T cell surveillance, the high degree of effectiveness of the immune checkpoint inhibitors...

Descripción completa

Detalles Bibliográficos
Autores principales:	D'Andréa, Grégoire, Lassalle, Sandra, Guevara, Nicolas, Mograbi, Baharia, Hofman, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738901/ https://www.ncbi.nlm.nih.gov/pubmed/33391536 http://dx.doi.org/10.7150/thno.50333

Ejemplares similares

The Importance of STK11/LKB1 Assessment in Non-Small Cell Lung Carcinomas
por: Mograbi, Baharia, et al.
Publicado: (2021)

Liquid Biopsy for Solid Ophthalmic Malignancies: An Updated Review and Perspectives
por: Martel, Arnaud, et al.
Publicado: (2020)

More light on cancer and COVID-19 reciprocal interaction
por: Brest, Patrick, et al.
Publicado: (2021)

Using Genetics To Dissect SARS-CoV-2 Infection
por: Brest, Patrick, et al.
Publicado: (2021)

COVID-19 vaccination and cancer immunotherapy: should they stick together?
por: Brest, Patrick, et al.
Publicado: (2021)

Never Travel Alone: The Crosstalk of Circulating Tumor Cells and the Blood Microenvironment
por: Heeke, Simon, et al.
Publicado: (2019)

Daily Practice Assessment of KRAS Status in NSCLC Patients: A New Challenge for the Thoracic Pathologist Is Right around the Corner
por: Bontoux, Christophe, et al.
Publicado: (2022)

Host Polymorphisms May Impact SARS-CoV-2 Infectivity
por: Brest, Patrick, et al.
Publicado: (2020)

Host genetic variability and determinants of severe COVID-19
por: Brest, Patrick, et al.
Publicado: (2023)

PD-L1 Expression in 65 Conjunctival Melanomas and Its Association with Clinical Outcome
por: Lassalle, Sandra, et al.
Publicado: (2020)

TIGIT as a Promising Therapeutic Target in Autoimmune Diseases
por: Yue, Chenran, et al.
Publicado: (2022)

Analysis of Blimp-1 and PD-1/PD-L1 Immune Checkpoint in an Autoimmune Thyroiditis Animal Model
por: Zhang, Xue, et al.
Publicado: (2020)

Assessment of Different Circulating Tumor Cell Platforms for Uveal Melanoma: Potential Impact for Future Routine Clinical Practice
por: Martel, Arnaud, et al.
Publicado: (2023)

HIF1A regulates xenophagic degradation of adherent and invasive Escherichia coli (AIEC)
por: Mimouna, Sanda, et al.
Publicado: (2015)

Ficolin-1 is a promising therapeutic target for autoimmune diseases
por: Katayama, Michihito, et al.
Publicado: (2018)

Expression of PD‐L1 in medullary thyroid carcinoma—a new therapeutic target?
por: Fonseca, Liliana, et al.
Publicado: (2021)

A novel Leishmania infantum nuclear phosphoprotein Lepp12 which stimulates IL1-beta synthesis in THP-1 transfectants
por: Fragaki, Konstantina, et al.
Publicado: (2003)

Anti-thyroid autoantibodies as biomarkers for alemtuzumab associated thyroid autoimmunity
por: Reindl, Markus
Publicado: (2019)

Reduced expression of PD-L1 in autoimmune thyroiditis attenuate trophoblast invasion through ERK/MMP pathway
por: Chen, Mengya, et al.
Publicado: (2019)

Collagen Family as Promising Biomarkers and Therapeutic Targets in Cancer
por: Necula, Laura, et al.
Publicado: (2022)

Need for a Dedicated Ophthalmic Malignancy Clinico-Biological Biobank: The Nice Ocular MAlignancy (NOMA) Biobank
por: Martel, Arnaud, et al.
Publicado: (2023)

Evaluation of Sample Pooling for SARS-CoV-2 Detection in Nasopharyngeal Swab and Saliva Samples with the Idylla SARS-CoV-2 Test
por: Hofman, Paul, et al.
Publicado: (2021)

Should evidence of an autolysosomal de-acidification defect in Alzheimer and Parkinson diseases call for caution in prescribing chronic PPI and DMARD?
por: Giuliano, Sandy, et al.
Publicado: (2023)

KIF11 Is a Promising Therapeutic Target for Thyroid Cancer Treatment
por: Han, Yue, et al.
Publicado: (2022)

PD-1/PD-L1 Inhibitors in Patients With Preexisting Autoimmune Diseases
por: Zhang, Ke, et al.
Publicado: (2022)

Promises and Pitfalls in the Use of PD-1/PD-L1 Inhibitors in Multiple Myeloma
por: Oliva, Stefania, et al.
Publicado: (2018)

GFAPδ: A Promising Biomarker and Therapeutic Target in Glioblastoma
por: Radu, Roxana, et al.
Publicado: (2022)

Retracted: KIF11 Is a Promising Therapeutic Target for Thyroid Cancer Treatment
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

T memory stem cell characteristics in autoimmune diseases and their promising therapeutic values
por: Fazeli, Pooria, et al.
Publicado: (2023)

HOTAIR is a promising novel biomarker in patients with thyroid cancer
por: Zhang, Yifei, et al.
Publicado: (2017)

Soluble PD‐L1 is a promising disease biomarker but does not reflect tissue expression in classic Hodgkin lymphoma
por: Veldman, Johanna, et al.
Publicado: (2021)

Focus on PD-1/PD-L1 as a Therapeutic Target in Ovarian Cancer
por: Dumitru, Adrian, et al.
Publicado: (2022)

The Promising Role of Non-Coding RNAs as Biomarkers and Therapeutic Targets for Leukemia
por: Ghazimoradi, Mohammad H., et al.
Publicado: (2023)

CEP55 as a promising biomarker and therapeutic target on gallbladder cancer
por: Huang, Maotuan, et al.
Publicado: (2023)

Therapeutic Use of Exercising in Hypoxia: Promises and Limitations
por: Millet, Gregoire P., et al.
Publicado: (2016)

Recent Advances in the Surgical Management of Thyroid Cancer
por: Scheller, Boris, et al.
Publicado: (2023)

Subversion of Autophagy in Adherent Invasive Escherichia coli-Infected Neutrophils Induces Inflammation and Cell Death
por: Chargui, Abderrahman, et al.
Publicado: (2012)

Sialylated immunoglobulin G: a promising diagnostic and therapeutic strategy for autoimmune diseases
por: Li, Danqi, et al.
Publicado: (2021)

Genetic biomarkers for PD-1/PD-L1 blockade therapy
por: Kataoka, Keisuke, et al.
Publicado: (2016)

Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors
por: Yi, Ming, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_l62588217gdn5o8aefha911q0s